Abstract
Acute lung injury is accompanied by an increased endothelial chemokine production and adhesion molecule expression, which may result in an extensive neutrophil infiltration. Moreover, a destruction of the alveolar epithelium and capillary endothelium may result in permeability edema. As such, the search for novel anti-inflammatory substances, able to downregulate these parameters as well as the tissue damage holds therapeutic promise. We therefore describe here the use of human endothelial cell-based in vitro assays for the detection of anti-inflammatory and wound-healing metabolites from cyanobacteria.
Original language | English |
---|---|
Pages (from-to) | 254-260 |
Number of pages | 7 |
Journal | Drug Metabolism Letters |
Volume | 1 |
Issue number | 4 |
DOIs | |
Publication status | Published - Dec 2007 |
Keywords
- antiinflammatory agent
- intercellular adhesion molecule 1
- acute lung injury
- article
- biological model
- cell line
- chemistry
- drug effect
- endothelium cell
- gene expression regulation
- human
- isolation and purification
- lung alveolus
- metabolism
- neutrophil chemotaxis
- Nostoc
- pathophysiology
- wound healing
- Acute Lung Injury
- Anti-Inflammatory Agents
- Cell Line
- Endothelial Cells
- Gene Expression Regulation
- Humans
- Intercellular Adhesion Molecule-1
- Models
- Biological
- Neutrophil Infiltration
- Pulmonary Alveoli
- Wound Healing
IMC Research Focuses
- Medical biotechnology
ÖFOS 2012 - Austrian Fields of Study
- 304005 Medical biotechnology